121 related articles for article (PubMed ID: 23328471)
1. [Expression and significance of MMP-9, PR, Ki-67 and Survivin in multiple meningiomas].
Gong J; Zhu SG; Wu CY; Li XG; Liu YG; Ren XH; Zhang Y
Zhonghua Yi Xue Za Zhi; 2012 Dec; 92(45):3218-20. PubMed ID: 23328471
[TBL] [Abstract][Full Text] [Related]
2. Detection of progesterone receptor and the correlation with Ki-67 labeling index in meningiomas.
Mukherjee S; Ghosh SN; Chatterjee U; Chatterjee S
Neurol India; 2011; 59(6):817-22. PubMed ID: 22234191
[TBL] [Abstract][Full Text] [Related]
3. [Expression of HER2/neu in meningiomas: an immunohistochemistry and fluorescence in situ hybridization study].
Wang CL; Mei JH; Wang SS; Xu S; Xu LL; Xiong YF
Zhonghua Bing Li Xue Za Zhi; 2010 Mar; 39(3):156-60. PubMed ID: 20450760
[TBL] [Abstract][Full Text] [Related]
4. Progesterone receptor expression and Ki-67 labelling index of meningiomas in the Lagos university teaching hospital.
Ikeri NZ; Anunobi CC; Bankole OB
Niger Postgrad Med J; 2018; 25(1):17-20. PubMed ID: 29676340
[TBL] [Abstract][Full Text] [Related]
5. [Aberrant methylation of NF2, TIMP-3 and THBS1 genes and their diagnostic values in meningiomas].
Gong J; Zhu SG; Wu CY; Li XG; Liu YG; Ren XH; Zhang Y
Zhonghua Yi Xue Za Zhi; 2012 Nov; 92(41):2889-92. PubMed ID: 23328233
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological characteristics, hormone receptor status and matrix metallo-proteinase-9 (MMP-9) immunohistochemical expression in spinal meningiomas.
Barresi V; Alafaci C; Caffo M; Barresi G; Tuccari G
Pathol Res Pract; 2012 Jun; 208(6):350-5. PubMed ID: 22494536
[TBL] [Abstract][Full Text] [Related]
7. The expression of survivin and Ki-67 in meningiomas: correlation with grade and clinical outcome.
Kayaselçuk F; Zorludemir S; Bal N; Erdogan B; Erdogan S; Erman T
J Neurooncol; 2004; 67(1-2):209-14. PubMed ID: 15072469
[TBL] [Abstract][Full Text] [Related]
8. Matrix metalloproteinase-2 and matrix metalloproteinase-9 expression in canine and feline meningioma.
Mandara MT; Pavone S; Mandrioli L; Bettini G; Falzone C; Baroni M
Vet Pathol; 2009 Sep; 46(5):836-45. PubMed ID: 19276056
[TBL] [Abstract][Full Text] [Related]
9. Expression of progestrone receptor and proliferative marker ki 67 in various grades of meningioma.
Shayanfar N; Mashayekh M; Mohammadpour M
Acta Med Iran; 2010; 48(3):142-7. PubMed ID: 21137648
[TBL] [Abstract][Full Text] [Related]
10. Gonadotropin-releasing hormone (GnRH) and its receptor in human meningiomas.
Hirota Y; Tachibana O; Uchiyama N; Hayashi Y; Nakada M; Kita D; Watanabe T; Higashi R; Hamada J; Hayashi Y
Clin Neurol Neurosurg; 2009 Feb; 111(2):127-33. PubMed ID: 18980792
[TBL] [Abstract][Full Text] [Related]
11. The Effect of Matrix Metalloproteinase-3 on the Prognosis and Biological Behaviour of Meningiomas.
Karaarslan N; Gurbuz MS; Caliskan T; Ayan E; Aker FV; Berkman MZ
Turk Neurosurg; 2016; 26(5):678-83. PubMed ID: 27438616
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors in anterior skull base meningiomas.
Ciocan LM; Dănăilă L; Stănculescu DE; Neamţu SD; Mateescu GO; Stanca L
Rom J Morphol Embryol; 2014; 55(3 Suppl):1063-9. PubMed ID: 25607386
[TBL] [Abstract][Full Text] [Related]
13. Proliferation and progesterone receptor status in benign meningiomas are not age dependent.
Roser F; Nakamura M; Ritz R; Bellinzona M; Dietz K; Samii M; Tatagiba MS
Cancer; 2005 Aug; 104(3):598-601. PubMed ID: 15952201
[TBL] [Abstract][Full Text] [Related]
14. Association of apparent diffusion coefficient with Ki-67 proliferation index, progesterone-receptor status and various histopathological parameters, and its utility in predicting the high grade in meningiomas.
Bozdağ M; Er A; Ekmekçi S
Acta Radiol; 2021 Mar; 62(3):401-413. PubMed ID: 32397733
[TBL] [Abstract][Full Text] [Related]
15. Recurrences of meningiomas: predictive value of pathological features and hormonal and growth factors.
Maiuri F; De Caro MB; Esposito F; Cappabianca P; Strazzullo V; Pettinato G; de Divitiis E
J Neurooncol; 2007 Mar; 82(1):63-8. PubMed ID: 17225937
[TBL] [Abstract][Full Text] [Related]
16. Clinical features and immunohistochemical expression levels of androgen, estrogen, progesterone and Ki-67 receptors in relationship with gross-total resected meningiomas relapse.
Tao Y; Liang G; Li Z; Wang Y; Wu A; Wang H; Lu Y; Liu Z; Hu G
Br J Neurosurg; 2012 Oct; 26(5):700-4. PubMed ID: 22616825
[TBL] [Abstract][Full Text] [Related]
17. Increased expression of avian erythroblastosis virus E26 oncogene homolog 1 in World Health Organization grade 1 meningiomas is associated with an elevated risk of recurrence and is correlated with the expression of its target genes matrix metalloproteinase-2 and MMP-9.
Okuducu AF; Zils U; Michaelis SA; Mawrin C; von Deimling A
Cancer; 2006 Sep; 107(6):1365-72. PubMed ID: 16894529
[TBL] [Abstract][Full Text] [Related]
18. Ets-1 is up-regulated together with its target gene products matrix metalloproteinase-2 and matrix metalloproteinase-9 in atypical and anaplastic meningiomas.
Okuducu AF; Zils U; Michaelis SA; Michaelides S; von Deimling A
Histopathology; 2006 Jun; 48(7):836-45. PubMed ID: 16722933
[TBL] [Abstract][Full Text] [Related]
19. Is progesteron receptor status really a prognostic factor for intracranial meningiomas?
Iplikcioglu AC; Hatiboglu MA; Ozek E; Ozcan D
Clin Neurol Neurosurg; 2014 Sep; 124():119-22. PubMed ID: 25036873
[TBL] [Abstract][Full Text] [Related]
20. Female predominance in meningiomas can not be explained by differences in progesterone, estrogen, or androgen receptor expression.
Korhonen K; Salminen T; Raitanen J; Auvinen A; Isola J; Haapasalo H
J Neurooncol; 2006 Oct; 80(1):1-7. PubMed ID: 16703453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
